A modular Programmed Death-Ligand 1 (PD-L1)-binding antigen presenter (PBAP) has been engineered to tether varicella-zoster virus (VZV) glycoprotein E (gE) to PD-L1 expressed on tumor cell surfaces. Here, CD274 is linked to neoplasm.